Latest Chemotherapy news
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer
posted October 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Olanzapine, Prochlorperazine Both Alleviate Refractory Chemo-Related Nausea
posted October 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
2023 Cisplatin Shortage Tied to Use of Alternatives for Head, Neck Cancer
posted October 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer
posted September 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing Related Articles
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Dexrazoxane Offers Lasting Doxorubicin Cardioprotective Effect in Childhood Cancer Survivors 
AMH Predicts Benefit of Chemo + Endocrine Therapy in Under 55s With Breast Cancer 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine Monthly Specialist Briefings
Stay Connected
